126 related articles for article (PubMed ID: 8045995)
1. [Noninvasive evaluation of chronic cumulative and acute cardiotoxicity induced by anthracycline in children with acute leukemia. Assessment of mainly left ventricular contractile state by M mode echocardiography].
Nakada S; Ogawa S; Hirayama T
Nihon Ika Daigaku Zasshi; 1994 Jun; 61(3):209-19. PubMed ID: 8045995
[TBL] [Abstract][Full Text] [Related]
2. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia.
Nysom K; Holm K; Lipsitz SR; Mone SM; Colan SD; Orav EJ; Sallan SE; Olsen JH; Hertz H; Jacobsen JR; Lipshultz SE
J Clin Oncol; 1998 Feb; 16(2):545-50. PubMed ID: 9469339
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal evaluation of anthracycline cardiotoxicity by signal-averaged electrocardiography in children with cancer.
Fukumi D; Uchikoba Y; Maeda M; Ogawa S
Pediatr Int; 2002 Apr; 44(2):134-40. PubMed ID: 11896869
[TBL] [Abstract][Full Text] [Related]
4. The value of echocardiography versus cardiac troponin I levels in the early detection of anthracycline cardiotoxicity in childhood acute leukemia: prospective evaluation of a 7-year-long clinical follow-up.
Oztarhan K; Guler S; Aktas B; Arslan M; Salcioglu Z; Aydogan G
Pediatr Hematol Oncol; 2011 Aug; 28(5):380-94. PubMed ID: 21699467
[TBL] [Abstract][Full Text] [Related]
5. Early detection of anthracycline cardiotoxicity in children with acute leukemia using exercise-based echocardiography and Doppler echocardiography.
Fukazawa R; Ogawa S; Hirayama T
Jpn Circ J; 1994 Aug; 58(8):625-34. PubMed ID: 7967004
[TBL] [Abstract][Full Text] [Related]
6. Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.
Vandecruys E; Mondelaers V; De Wolf D; Benoit Y; Suys B
J Cancer Surviv; 2012 Mar; 6(1):95-101. PubMed ID: 21630046
[TBL] [Abstract][Full Text] [Related]
7. Anthracycline-induced cardiotoxicity in children with malignancies.
Godoy LY; Fukushige J; Igarashi H; Matsuzaki A; Ueda K
Acta Paediatr Jpn; 1997 Apr; 39(2):188-93. PubMed ID: 9141252
[TBL] [Abstract][Full Text] [Related]
8. Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors.
Amigoni M; Giannattasio C; Fraschini D; Galbiati M; Capra AC; Madotto F; Cesana F; Jankovic M; Masera G; Mancia G
Pediatr Blood Cancer; 2010 Dec; 55(7):1343-7. PubMed ID: 20589666
[TBL] [Abstract][Full Text] [Related]
9. Late cardiotoxicity of anthracyclines in children with acute leukemia.
Zalewska-Szewczyk B; Lipiec J; Bodalski J
Klin Padiatr; 1999; 211(4):356-9. PubMed ID: 10472576
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of left ventricular function in asymptomatic children about to undergo anthracycline-based chemotherapy for acute leukemia: an outcome study.
Porea TJ; Dreyer ZE; Bricker JT; Mahoney DH
J Pediatr Hematol Oncol; 2001 Oct; 23(7):420-3. PubMed ID: 11878575
[TBL] [Abstract][Full Text] [Related]
11. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.
Sorensen K; Levitt G; Bull C; Chessells J; Sullivan I
J Clin Oncol; 1997 Jan; 15(1):61-8. PubMed ID: 8996125
[TBL] [Abstract][Full Text] [Related]
12. The role of biomarkers and echocardiography in the evaluation of cardiotoxicity risk in children treated for leukemia.
Raluca Maniu D; Blag C; Popa G; Bota M; Vlad C; Cainap C; Balacescu O; Pop L; Cainap SS
J BUON; 2018 Dec; 23(7):122-131. PubMed ID: 30722121
[TBL] [Abstract][Full Text] [Related]
13. Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.
Sági JC; Egyed B; Kelemen A; Kutszegi N; Hegyi M; Gézsi A; Herlitschke MA; Rzepiel A; Fodor LE; Ottóffy G; Kovács GT; Erdélyi DJ; Szalai C; Semsei ÁF
BMC Cancer; 2018 Jul; 18(1):704. PubMed ID: 29970035
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors of Daunorubicine Induced Early Cardiotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Study.
Samosir SM; Utamayasa IKA; Andarsini MR; Rahman MA; Ontoseno T; Hidayat T; Ugrasena IDG; Larasati MCS; Cahyadi A
Asian Pac J Cancer Prev; 2021 May; 22(5):1407-1412. PubMed ID: 34048168
[TBL] [Abstract][Full Text] [Related]
15. [Echocardiographic assessment of circulation system in patients during and 3-5 years after all therapy in childhood].
Ostański M; Sońta-Jakimczyk D
Wiad Lek; 2002; 55(3-4):164-73. PubMed ID: 12182001
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cardiomyopathy in acute myeloid leukemia patients treated with anthracyclines.
Mort MK; Sen JM; Morris AL; DeGregory KA; McLoughlin EM; Mort JF; Dunn SP; Abuannadi M; Keng MK
J Oncol Pharm Pract; 2020 Apr; 26(3):680-687. PubMed ID: 31500517
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cardiac reserved function by high-dose dobutamine-stress echocardiography in asymptomatic anthracycline-treated survivors of childhood cancer.
Hamada H; Ohkubo T; Maeda M; Ogawa S
Pediatr Int; 2006 Jun; 48(3):313-20. PubMed ID: 16732801
[TBL] [Abstract][Full Text] [Related]
18. Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study.
Linares Ballesteros A; Sanguino Lobo R; Villada Valencia JC; Arévalo Leal O; Plazas Hernández DC; Aponte Barrios N; Perdomo Ramírez I
Colomb Med (Cali); 2021 Feb; 52(1):e2034542. PubMed ID: 33911320
[TBL] [Abstract][Full Text] [Related]
19. Does anthracycline administration by infusion in children affect late cardiotoxicity?
Levitt GA; Dorup I; Sorensen K; Sullivan I
Br J Haematol; 2004 Feb; 124(4):463-8. PubMed ID: 14984495
[TBL] [Abstract][Full Text] [Related]
20. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
Rathe M; Carlsen NL; Oxhøj H
Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
